Stay updated on RGX-111 Gene Therapy in MPS I Clinical Trial
Sign up to get notified when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.

Latest updates to the RGX-111 Gene Therapy in MPS I Clinical Trial page
- Check5 days agoChange DetectedThe screenshots show only cosmetic layout and formatting differences, with no changes to the main study details or outcomes.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: page now includes government funding status notice and updated operating details, plus a new version tag v3.2.0. Removed a specific condition (Mucopolysaccharidosis type 1) and the old version tag.SummaryDifference4%

- Check41 days agoChange DetectedMinor corrections: standardize the medical condition name capitalization and bump the revision to v3.1.0.SummaryDifference0.2%

- Check55 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated to include specific facility names and locations, as well as detailed information about publications related to Mucopolysaccharidosis type 1 and associated syndromes. Notably, the page has removed several terms and references that were previously included.SummaryDifference10%

Stay in the know with updates to RGX-111 Gene Therapy in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.